RANK as a Therapeutic Target in Cancer

    January 2016 in “ ˜The œFEBS journal ”
    Eva González‐Suárez, Adrián Sanz‐Moreno
    Studysummary This review discusses the various roles of RANK signaling in bone remodeling, immune function, and epithelial differentiation, highlighting its potential involvement in cancer mechanisms; it reports no new clinical results.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on onlinelibrary.wiley.com →
    Discuss this study in the Community →

    Research cited in this study 1

    1. Receptor Activator of NF-κB Stimulates the Proliferation of Epithelial Cells of the Epidermo-Pilosebaceous Unit Proceedings of the National Academy of Sciences of the United States of America · 2011